Cargando…

Hematinic and Iron Optimization in Peri-operative Anemia and Iron Deficiency

PURPOSE OF REVIEW: Preoperative anemia is independently associated with worse postoperative outcomes following cardiac and noncardiac surgery. This article explores the current understanding of perioperative anemia and iron deficiency with reference to definition, diagnosis, and treatment. RECENT FI...

Descripción completa

Detalles Bibliográficos
Autores principales: Miles, Lachlan F., Richards, Toby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766356/
https://www.ncbi.nlm.nih.gov/pubmed/35069018
http://dx.doi.org/10.1007/s40140-021-00503-z
_version_ 1784634511218180096
author Miles, Lachlan F.
Richards, Toby
author_facet Miles, Lachlan F.
Richards, Toby
author_sort Miles, Lachlan F.
collection PubMed
description PURPOSE OF REVIEW: Preoperative anemia is independently associated with worse postoperative outcomes following cardiac and noncardiac surgery. This article explores the current understanding of perioperative anemia and iron deficiency with reference to definition, diagnosis, and treatment. RECENT FINDINGS: Iron deficiency is the most common cause of anemia. It can arise from reduced iron intake, poor absorption, or excess iron loss. Inflammation throughout the preoperative period can drive iron sequestration, leading to a functional deficiency of iron and the development of what was referred to until recently as the “anemia of chronic disease.” Current best practice guidance supports the routine administration of preoperative intravenous iron to treat anemia despite limited evidence. This “one size fits all” approach has been called into question following results from a recent large, randomized trial (the PREVENTT trial) that assessed the use of a single dose of intravenous iron compared to placebo 10–42 days before major abdominal surgery. Although there were no improvements in patient-centered outcomes apparent during the initial hospital stay, secondary endpoints of this trial suggested there may be some late benefit after discharge from the hospital (8 weeks postoperatively). This trial raises questions on (1) the mechanisms of iron deficiency in the perioperative patient; (2) the need to reassess our opinions on generic anemia management; and (3) the need to address patient outcomes after discharge from hospital. SUMMARY: Despite the known associations between preoperative anemia (particularly iron deficiency anemia) and poor postoperative outcome, recent evidence suggests that administering intravenous iron relatively close to surgery does not yield a tangible short-term benefit. This is made more complex by the interplay between iron and innate immunity. Iron deficiency irrespective of hemoglobin concentration may also impact postoperative outcomes. Therefore, further research into associations between iron deficiency and postoperative outcomes, and between postoperative anemia, delayed outcomes (hospital readmission), and the efficacy of postoperative intravenous iron is required.
format Online
Article
Text
id pubmed-8766356
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-87663562022-01-19 Hematinic and Iron Optimization in Peri-operative Anemia and Iron Deficiency Miles, Lachlan F. Richards, Toby Curr Anesthesiol Rep Prehabilitation (B Riedel and S Jack, Section Editors) PURPOSE OF REVIEW: Preoperative anemia is independently associated with worse postoperative outcomes following cardiac and noncardiac surgery. This article explores the current understanding of perioperative anemia and iron deficiency with reference to definition, diagnosis, and treatment. RECENT FINDINGS: Iron deficiency is the most common cause of anemia. It can arise from reduced iron intake, poor absorption, or excess iron loss. Inflammation throughout the preoperative period can drive iron sequestration, leading to a functional deficiency of iron and the development of what was referred to until recently as the “anemia of chronic disease.” Current best practice guidance supports the routine administration of preoperative intravenous iron to treat anemia despite limited evidence. This “one size fits all” approach has been called into question following results from a recent large, randomized trial (the PREVENTT trial) that assessed the use of a single dose of intravenous iron compared to placebo 10–42 days before major abdominal surgery. Although there were no improvements in patient-centered outcomes apparent during the initial hospital stay, secondary endpoints of this trial suggested there may be some late benefit after discharge from the hospital (8 weeks postoperatively). This trial raises questions on (1) the mechanisms of iron deficiency in the perioperative patient; (2) the need to reassess our opinions on generic anemia management; and (3) the need to address patient outcomes after discharge from hospital. SUMMARY: Despite the known associations between preoperative anemia (particularly iron deficiency anemia) and poor postoperative outcome, recent evidence suggests that administering intravenous iron relatively close to surgery does not yield a tangible short-term benefit. This is made more complex by the interplay between iron and innate immunity. Iron deficiency irrespective of hemoglobin concentration may also impact postoperative outcomes. Therefore, further research into associations between iron deficiency and postoperative outcomes, and between postoperative anemia, delayed outcomes (hospital readmission), and the efficacy of postoperative intravenous iron is required. Springer US 2022-01-19 2022 /pmc/articles/PMC8766356/ /pubmed/35069018 http://dx.doi.org/10.1007/s40140-021-00503-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Prehabilitation (B Riedel and S Jack, Section Editors)
Miles, Lachlan F.
Richards, Toby
Hematinic and Iron Optimization in Peri-operative Anemia and Iron Deficiency
title Hematinic and Iron Optimization in Peri-operative Anemia and Iron Deficiency
title_full Hematinic and Iron Optimization in Peri-operative Anemia and Iron Deficiency
title_fullStr Hematinic and Iron Optimization in Peri-operative Anemia and Iron Deficiency
title_full_unstemmed Hematinic and Iron Optimization in Peri-operative Anemia and Iron Deficiency
title_short Hematinic and Iron Optimization in Peri-operative Anemia and Iron Deficiency
title_sort hematinic and iron optimization in peri-operative anemia and iron deficiency
topic Prehabilitation (B Riedel and S Jack, Section Editors)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766356/
https://www.ncbi.nlm.nih.gov/pubmed/35069018
http://dx.doi.org/10.1007/s40140-021-00503-z
work_keys_str_mv AT mileslachlanf hematinicandironoptimizationinperioperativeanemiaandirondeficiency
AT richardstoby hematinicandironoptimizationinperioperativeanemiaandirondeficiency